Atlas Trials

Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors

Clinical trial NCT01217450 · COMPLETED

Trial details

NCT number
NCT01217450
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal CancerUnspecified Adult Solid Tumor, Protocol Specific
Start date
2012-10-01
Primary completion
2012-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.